The significant REDD1 up-regulation is found in bladder urothelial carcinoma, oral squamous cell carcinoma, ovarian cancer, myeloid leukemia, and glioblastoma multiform and is associated with poor outcomes [8,54,55,56]. The gene discussed is DDIT4; the disease is ovarian cancer.